Press release

Press Release

Cision PR Newswire3 weeks ago
0

Argus launches northeast Asia naphtha price

Price series brings new regional transparency to reflect rising trade to China SINGAPORE, Nov. 26, 2025 /PRNewswire/ — Global energy…
Read More »
Cision PR Newswire3 weeks ago
0

The Persistence of Seeking Knowledge in the Flames of War

GUIYANG, China, Nov. 26, 2025 /PRNewswire/ — During the World Anti-Fascist War, many Chinese universities relocated to Guizhou. Institutions such…
Read More »
Press Release

Cision PR Newswire3 weeks ago
0

AEWIN Introduces BIS-5132 Series — 2U High-Performance General-Purpose Servers Powered by Intel Xeon 6 Processors

TAIPEI, Nov. 26, 2025 /PRNewswire/ — AEWIN unveils the BIS-5132-2U, a versatile 2U general-purpose server powered by Intel’s latest Xeon…
Read More »
Business Wire3 weeks ago

With Two in Five Employees Undergoing Fertility Treatment Leaving Their Jobs or Considering Quitting, Are Companies Doing Enough?

SAINT-PREX, Switzerland–(BUSINESS WIRE)–An international survey, spanning Australia, France, Japan, Poland and the UK, has found that many employees experiencing fertility…
Read More »
Business Wire3 weeks ago

WeRide and Uber Launch Middle East’s First Fully Driverless Robotaxi Commercial Operations in Abu Dhabi, UAE

The launch was supported by the world’s first city-level fully driverless Robotaxi permit outside the United States (U.S.) Abu Dhabi…
Read More »
Press Release

Cision PR Newswire3 weeks ago
0

The Rise of Cloud Phones: How GeeLark Is Redefining Social Media Marketing

SINGAPORE, Nov. 25, 2025 /PRNewswire/ — In the past decade, social media marketing has undergone one transformation after another —…
Read More »
Cision PR Newswire3 weeks ago
0

Curasight’s uTREAT® Phase 1 Trial in Brain Cancer Now Open for Patient Enrollment

Phase 1 study in aggressive brain cancer (Glioblastoma) is the first clinical trial investigation of uTREAT® Site given green light…
Read More »
Press Release

Cision PR Newswire3 weeks ago
0

Celltrion announces publication of post-hoc analysis of LIBERTY-CD study of ZYMFENTRA® (infliximab-dyyb), indicating consistent efficacy across disease location, including the terminal ileum in Clinical Gastroenterology and Hepatology journal

Findings from the post-hoc analysis of LIBERTY-CD study indicates efficacy of ZYMFENTRA® (subcutaneous infliximab) regardless of disease location, consistent across ileum-dominant…
Read More »
Cision PR Newswire3 weeks ago
0

Gaotu Techedu Announces Third Quarter 2025 Unaudited Financial Results

BEIJING, Nov. 26, 2025 /PRNewswire/ — Gaotu Techedu Inc. (NYSE: GOTU) (“Gaotu” or the “Company”), a leading technology-driven education company…
Read More »
Business Wire3 weeks ago

A New Era of Sovereign AI: Dassault Systèmes and Mistral AI Deepen Their Partnership

Mistral AI’s “Le Chat Enterprise” AI assistant and “AI Studio” builder platform are now available on Dassault Systèmes’ OUTSCALE sovereign…
Read More »

Previous page Next page